115 related articles for article (PubMed ID: 37953652)
1. One-hour post-load glucose levels are associated with hepatic steatosis assessed by transient elastography.
Andreozzi F; Mancuso E; Mazza E; Mannino GC; Fiorentino TV; Arturi F; Succurro E; Perticone M; Sciacqua A; Montalcini T; Pujia A; Sesti G
Diabetes Obes Metab; 2024 Feb; 26(2):682-689. PubMed ID: 37953652
[TBL] [Abstract][Full Text] [Related]
2. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
3. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
[TBL] [Abstract][Full Text] [Related]
4. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
5. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
[TBL] [Abstract][Full Text] [Related]
7. Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Han E; Kim MK; Jang BK; Kim HS
Diabetes Metab J; 2021 Sep; 45(5):698-707. PubMed ID: 33517613
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018.
Bae JC; Beste LA; Utzschneider KM
Endocrinol Metab (Seoul); 2022 Jun; 37(3):455-465. PubMed ID: 35726152
[TBL] [Abstract][Full Text] [Related]
10. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
Kim G; Kim KJ; Rhee Y; Lim SK
PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
[TBL] [Abstract][Full Text] [Related]
11. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
12. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
13. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.
Wang D; Nan N; Bing H; He B
Front Endocrinol (Lausanne); 2023; 14():1241734. PubMed ID: 37720537
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes.
Pozzan R; Pena RG; Palma CCSSV; de Carvalho Abi-Abib R; Terra C; Cobas RA
Arch Endocrinol Metab; 2022 Sept 08; 66(4):452-458. PubMed ID: 35657127
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome.
Shengir M; Krishnamurthy S; Ghali P; Deschenes M; Wong P; Chen T; Sebastiani G
World J Gastroenterol; 2020 Nov; 26(44):7046-7060. PubMed ID: 33311949
[TBL] [Abstract][Full Text] [Related]
16. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
17. The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population.
Trivedi HD; Suri J; Oh D; Schwartz J; Goyes D; Idriss R; Curry MP; Lai M
Ann Hepatol; 2021; 24():100336. PubMed ID: 33647502
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound and FibroScan
Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
[TBL] [Abstract][Full Text] [Related]
19. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
Xie Y; Kong W; Wang X; Wu Z
BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
[TBL] [Abstract][Full Text] [Related]
20. Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.
Huang Z; Ng K; Chen H; Deng W; Li Y
Front Endocrinol (Lausanne); 2021; 12():739875. PubMed ID: 35173677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
